Lara-Aguilar Violeta, Valle-Millares Daniel, Crespo-Bermejo Celia, Grande-García Sergio, Llamas-Adán Manuel, Cortijo-Alfonso María Engracia, Martín-Carbonero Luz, Domínguez Lourdes, Ryan Pablo, de Los Santos Ignacio, Bartolomé-Sánchez Sofía, Vidal-Alcántara Erick Joan, Jiménez-Sousa María Angeles, Fernández-Rodríguez Amanda, Briz Verónica
Viral Hepatitis Reference and Research Laboratory, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
Internal Medicine Service, La Paz University Hospital (IdiPAZ), Madrid, Spain.
Biomed Pharmacother. 2023 Jun;162:114664. doi: 10.1016/j.biopha.2023.114664. Epub 2023 Apr 7.
We identified that acute or chronic Hepatitis C (HCV) infection in people living with HIV (PLWHIV) results in different senescence profiles. However, variations in these profiles after HCV elimination, spontaneously or with direct-acting antivirals (DAAs), remain unclear.
Longitudinal observational study (48 weeks) in 70 PLWHIV: 23 PLWHIV with active HCV-chronic infection (CHC) before and after HCV eradication with DAAs, 12 PLWHIV who spontaneously clarify the HCV (SC), and 35 controls (HIV). Oxidative stress was quantified at DNA, lipid, protein, and nitrate levels, as well as the antioxidant capacity and glutathione enzyme. The replicative senescence was evaluated by relative telomere length measurement by PCR and twenty-six factors related to Senescence-Associated Secretory Phenotype (SASP) were characterized by Luminex. Differences in senescence markers was evaluated by generalized linear models.
During follow-up, the SC group achieved a significant improvement in glutathione enzyme and lipid peroxidation. The secretion of SASP markers increased but was still lower than that of the HIV group. Overall, the CHC group reduced the levels of oxidative stress and SASP markers to levels like those of the HIV group. No significant differences in telomere shortening were observed between groups.
As the time since spontaneous resolution of HCV infection increased, patients had an improved senescence profile compared to the HIV group. Elimination of chronic HCV infection by DAAs led to a partial improvement of the senescent profile by restoring oxidative stress levels. However, although some SASP markers reached levels like those of the HIV group, others remained altered.
我们发现,感染人类免疫缺陷病毒(HIV)的人群(PLWHIV)中,急性或慢性丙型肝炎病毒(HCV)感染会导致不同的衰老特征。然而,HCV自发清除或使用直接抗病毒药物(DAA)清除后,这些特征的变化仍不清楚。
对70名PLWHIV进行纵向观察研究(48周):23名PLWHIV在使用DAA根除HCV前后患有活动性HCV慢性感染(CHC),12名PLWHIV自发清除HCV(SC),以及35名对照者(HIV)。在DNA、脂质、蛋白质和硝酸盐水平以及抗氧化能力和谷胱甘肽酶方面对氧化应激进行量化。通过PCR测量相对端粒长度来评估复制性衰老,并通过Luminex对与衰老相关分泌表型(SASP)相关的26个因子进行表征。通过广义线性模型评估衰老标志物的差异。
在随访期间,SC组的谷胱甘肽酶和脂质过氧化有显著改善。SASP标志物的分泌增加,但仍低于HIV组。总体而言,CHC组将氧化应激和SASP标志物水平降低至与HIV组相似的水平。各组之间未观察到端粒缩短的显著差异。
随着HCV感染自发清除时间的增加,与HIV组相比,患者的衰老特征有所改善。通过DAA消除慢性HCV感染可通过恢复氧化应激水平部分改善衰老特征。然而,尽管一些SASP标志物达到了与HIV组相似的水平,但其他标志物仍有改变。